Answers are grounded in this paper and cite their sources.
Clinical review highlights safe and effective light therapies for psoriasis, indicating structured regimens optimize outcomes while minimizing risks.
Psoriasis is a chronic, multisystem inflammatory disease, predominantly affecting the skin and joints, which is present in 2-3% of the world's population. Narrow band ultraviolet B (NB-UVB) and Psoralen + ultraviolet A (PUVA) are recognised, effective and, in the case of UVB, economical second-line treatments for psoriasis where topical therapies fail to control the disease or are an impracticable option due to the extent of skin involvement. This article examines the history of phototherapy and photochemotherapy and looks at current phototherapy treatments used for psoriasis. It discusses side effects of treatment and regimens that can be followed to increase effectiveness of treatment and minimise risks. The role of the nurse phototherapist is also discussed.
No takes yet. Share an insight, caveat, or question.
Joanna Campbell (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: